Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rectal Neoplasms 5Colorectal Neoplasms 4Barrett Esophagus 3Adenocarcinoma Of Esophagus 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Esophageal Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Urogenital Neoplasms 1Upper Tract Urothelial Carcinoma 1Squamous Cell Carcinoma of Head and Neck 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms 1Lymphoma, Primary Effusion 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Lung Neoplasms 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Fistula 1Esophageal Squamous Cell Carcinoma 1Disease 1Colitis 1Clinical Stage III Gastric Cancer AJCC v8 1Carcinoma, Non-Small-Cell Lung 1Bacteremia 1Adenoma 1Adenocarcinoma 1

Interventions

Infliximab 3Fecal Microbiota Transplantation 3vedolizumab 2Prednisone 2LDP-02 2Immunoglobulin G 2Disulfides 2CT-P13 2prednylidene 1deltacortene 1Standard of Care 1Practice Guidelines as Topic 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Loperamide 1Endoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colitis × Endoscopy × 1 year × Clear all
NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

M.D. Anderson Cancer Center

Phase 1 Recruiting
800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡